187660 — Penetrium Bioscience Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Penetrium Bioscience, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,727	-58.9	-3,363	-20,260	-14,830
Depreciation
Amortisation
Non-Cash Items	990	130	782	4,649	8,739
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-2,681	-253	-2,055	-270	503
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	738	904	-3,078	-14,292	-4,475
Capital Expenditures	-1,102	-1,572	-625	-96.7	-773
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-19,431	-7,577	4,352	15,530	-133
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-20,533	-9,149	3,727	15,433	-906
Financing Cash Flow Items	—	-586	321	-8.72	-17.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	16,500	6,073	-374	1,265	4,383
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-3,295	-2,173	275	2,406	-998